secwatch.observer — SEC 8-K summary
======================================

Issuer:     Praxis Precision Medicines, Inc. (PRAX)
CIK:        0001689548
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001689548-24-000073
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Praxis Precision Medicines shareholders approve 870K share increase for 2020 equity plan
--------------------------------------------------------------------------------

- Stockholders elected Dean Mitchell and Jill DeSimone as Class I directors for terms ending 2027.
- Ratified Ernst & Young as independent auditor for FY 2024 with 15.3M votes for.
- Approved amendment to 2020 Stock Plan, increasing authorized shares by 870,000 (9.1M for, 5.1M against).
- Advisory vote on executive compensation passed with 10.0M for, 4.1M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/0001689548-24-000073-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1689548/000168954824000073/prax-20240605.htm
  HTML page:      https://secwatch.observer/filing/0001689548-24-000073

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer